Regis Resources Ltd (RRL)
Australian Securities Exchange · Australia · prices in AUD · close of 22 Oct 2026
Key indicators
| Last close | AUD 6.380 |
|---|---|
| 52-week range | 5.335 – 10.000 |
| Return, 1 month / 3 months | −18.3% / +4.0% |
| Return, 1 year / 3 years | +11.4% / +310.2% |
| Trend | Below its 200-day average |
| RSI (14) | 28 |
| Volatility (1 year) | 53.8% |
| Worst drawdown (1 year) | -41.8% |
| Average daily value traded | 25.48M AUD |
| Dividend yield | 5.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Regis Resources is an Australian gold producer that explores for, mines and processes gold. The company operates mines and processing plants in Western Australia, where it extracts ore and turns it into gold doré bars for refining. Its activities span exploration, open-pit and underground mining, and mineral processing, and its customers are the refiners and bullion markets that take its gold output. Regis Resources is based in Perth, Western Australia.
On this site Regis Resources Ltd appears as a stock on the Australian Securities Exchange (Australia), code RRL, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Regis Resources Ltd (RRL) trades on the Australian Securities Exchange in Australia. It last closed at AUD 6.380 on 22 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 394 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 11.4% and over the last three months it rose 4.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -9.9% | ||
| From 52-week high | -34.6% | ||
| Momentum | 70 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 4.0% | ||
| 6-month return | -13.0% | ||
| 12-month return, skipping the last month | 36.4% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 53.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.8% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 25.48M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 38 · Weak | Dividend is small or irregular. | |
| Dividend yield | 5.5% | ||
| Years with dividends | 3 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −6.9% |
|---|---|
| 1 month | −18.3% |
| 3 months | +4.0% |
| 6 months | −13.0% |
| 1 year | +11.4% |
| 3 years | +310.2% |
| 5 years | +206.8% |
Signals
| 50-day / 200-day average | 7.591 / 7.079 |
|---|---|
| Golden / death cross (60 days) | Golden, 27 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.280 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | AUD 0.2000 |
| 12 Mar 2026 | AUD 0.1500 |
| 10 Sep 2025 | AUD 0.0500 |
| 12 Oct 2022 | AUD 0.0200 |
| 13 Sep 2021 | AUD 0.0300 |
| 10 Mar 2021 | AUD 0.0386 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.